Overall rank by patents
#4,022
of 49,997 tracked assignees
USPTO PatentsView assignee record - 90 granted patents across 27 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Santen ranks #4,022 of 49,997 tracked US assignees by granted-patent volume, with 90 patents across 27 technology areas.
USPTO PatentsView assignee plate
Corpus R4022 · Foreign Corporation #4,022 · 90 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: NKT Photonics A/S (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Diveplane · near
44 score
Doskocil Manufacturing · near
44 score
Santa Clara University · near
44 score
Santen Pharmaceutical · this assignee
44 score
Teva Pharmaceutical… · near
44 score
3D Lighting… · lowest
7 score
What this shows Santen's Innovation Score is 44.5/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Santen Pharmaceutical Co., Ltd. is a focused PatentsView assignee: 27 CPC subclasses with 75.6% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (17 grants) versus a trough of 4 in 2024. By volume, Santen sits between NKT Photonics A/S and Tristar Products, Inc..
From 2019–2021 to 2022–2024, Santen Pharmaceutical Co., Ltd. moved from 25 to 17 grants (0.68x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NKT Photonics A/S
90 patents
Nuro, Inc.
90 patents
Pierburg Pump Technology GMBH
90 patents
Quanta Associates, L.P.
90 patents
Soletanche Freyssinet
90 patents
SureFire, LLC
90 patents
Toyota Motor Europe
90 patents
Tristar Products, Inc.
90 patents
Santen Pharmaceutical Co., Ltd.
90 patents
What this shows Santen holds 90 patents at rank #4,022, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,022 in granted patent volume.
Other assignees with the most granted patents in Santen's primary technology class.
Two PlainPatent-derived peer sets for Santen, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (44 here).
Nearest assignees by average claims per patent (10.0 here).
Santen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 25% higher than 75% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 17 | 18.9% |
| 2016 | 10 | 11.1% |
| 2017 | 8 | 8.9% |
| 2018 | 9 | 10.0% |
| 2019 | 7 | 7.8% |
| 2020 | 10 | 11.1% |
| 2021 | 8 | 8.9% |
| 2022 | 8 | 8.9% |
| 2023 | 5 | 5.6% |
| 2024 | 4 | 4.4% |
| 2025partial year | 4 | 4.4% |
Top 15 of 27 technology areas
Overall rank by patents
#4,022
of 49,997 tracked assignees
44.5 out of 100
What to do with this data
Santen Pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.